l 163191 has been researched along with hki 272 in 2 studies
Studies (l 163191) | Trials (l 163191) | Recent Studies (post-2010) (l 163191) | Studies (hki 272) | Trials (hki 272) | Recent Studies (post-2010) (hki 272) |
---|---|---|---|---|---|
35 | 0 | 17 | 283 | 42 | 248 |
Protein | Taxonomy | l 163191 (IC50) | hki 272 (IC50) |
---|---|---|---|
Epidermal growth factor receptor | Homo sapiens (human) | 0.0416 | |
Receptor tyrosine-protein kinase erbB-2 | Homo sapiens (human) | 0.0298 | |
Vascular endothelial growth factor receptor 2 | Homo sapiens (human) | 0.8582 | |
Serine/threonine-protein kinase Nek2 | Homo sapiens (human) | 0.274 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 2 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Davis, MI; Khan, J; Li, SQ; Patel, PR; Shen, M; Sun, H; Thomas, CJ | 1 |
Kabir, M; Kerns, E; Nguyen, K; Shah, P; Sun, H; Wang, Y; Xu, X; Yu, KR | 1 |
2 other study(ies) available for l 163191 and hki 272
Article | Year |
---|---|
Identification of potent Yes1 kinase inhibitors using a library screening approach.
Topics: Binding Sites; Cell Line; Cell Survival; Drug Design; Humans; Hydrogen Bonding; Molecular Docking Simulation; Protein Kinase Inhibitors; Protein Structure, Tertiary; Proto-Oncogene Proteins c-yes; Small Molecule Libraries; Structure-Activity Relationship | 2013 |
Predictive models of aqueous solubility of organic compounds built on A large dataset of high integrity.
Topics: Drug Discovery; Organic Chemicals; Pharmaceutical Preparations; Solubility | 2019 |